一个家庭干预,延迟阿尔茨海默病患者的养老院安置. 一个随机对照试验
M S Mittelman1, S H Ferris, E Shulman
1Aging and Dementia Research Center, New York University Medical Center, NY 10016, USA.
JAMA
|December 4, 1996
概括
综合性支持和咨询通过增加护理人员的能力,显著延迟了阿尔茨海默病 (AD) 患者的养老院安置. 这种干预有助于家庭更长时间地维持家庭护理,特别是在早期到中度痴呆阶段.
科学领域:
- 老年学是指老年学的学科.
- 精神病学是一个精神病学.
- 公共卫生 公共卫生
背景情况:
- 阿尔茨海默氏症 (AD) 对配偶照顾者造成了重大负担,往往导致养老院安置.
- 需要有效的干预措施来支持护理人员,并延长阿兹海默症患者的家庭护理.
研究的目的:
- 评估对配偶-护理人员的综合支持和咨询的长期有效性,以延迟阿兹海默症患者的养老院安置.
主要方法:
- 一项随机对照干预研究,涉及206名在家生活的阿兹海默症患者的配偶护理人员.
- 治疗组接受了6个辅导会议和支持小组,随着辅导员的持续可用性.
- 时间到养老院安置是主要的结果指标.
主要成果:
- 对于那些护理人员获得支持和咨询的患者来说,安置在养老院的中位时间比安置在养老院的时间长329天.
- 治疗组的护理人员将配偶安置在养老院的可能性大约为三分之二 (相对风险=0.65).
- 该干预措施在推迟轻度或中度痴呆症患者的安置方面最有效.
结论:
- 咨询和支持计划显著延长了阿尔茨海默病患者在家护理的持续时间.
- 这种方法对痴呆症早期到中期阶段的患者尤其有益.
相关概念视频
01:22Alzheimer's Disease: Treatment
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
01:29Alzheimer Disease l: Introduction
Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...